lilly tirzepatide vial releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Zepbound® (tirzepatide) is now on

The Journal of Nursing Research : JNR, 33 (6), e428

If a pen freezes, it should not be used

Thyroid Monitoring While Taking Semaglutide Regular TSH and free T4 testing forms the foundation of safe semaglutide use in hypothyroid patients

Common MOTS-c side effects and how they present The most frequently reported side effects fall into predictable categories based on the mechanisms we just discussed

Taken together, combining an SGLT-2 inhibitor with a GLP-1 receptor agonist in people with type 2 diabetes is associated with lower risk of major cardiovascular events, mortality, heart failure hospitalisations and adverse kidney outcomes compared with monotherapy based on a meta-analysis of 18 cohort studies with 1,164,774 participants [36]